|
1
|
Tatemoto K, Hosoya M, Habata Y, et al:
Isolation and characterization of a novel endogenous peptide ligand
for the human APJ receptor. Biochem Biophys Res Commun.
251:471–476. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Carroll AM, Selby TL, Palkovits M and
Lolait SJ: Distribution of mRNA encoding B78/apj, the rat homologue
of the human APJ receptor, and its endogenous ligand apelin in
brain and peripheral tissues. Biochim Biophys Acta. 1492:72–80.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sunter D, Hewson AK and Dickson SL:
Intracerebroventricular injection of apelin-13 reduces food intake
in the rat. Neurosci Lett. 353:1–4. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishida J, Hashimoto T, Hashimoto Y, et al:
Regulatory roles for APJ, a seven-transmembrane receptor related to
angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem.
279:26274–26279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akcılar R, Turgut S, Caner V, Akcılar A,
Ayada C, Elmas L and Özcan TO: Apelin effects on blood pressure and
RAS in DOCA-salt-induced hypertensive rats. Clin Exp Hypertens.
35:550–557. 2013. View Article : Google Scholar
|
|
6
|
Jeong K, Oh Y, Kim S-J, Kim H, Park KC,
Kim SS, Ha J, Kang I and Choe W: Apelin is transcriptionally
regulated by ER stress-induced ATF4 expression via a p38
MAPK-dependent pathway. Apoptosis. 19:1399–1410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Li L, Xie F, Zhang Z, Guo Y, Tang G,
Lv D, Lu Q, Chen L and Li J: Jagged-1/Notch3 signaling transduction
pathway is involved in apelin-13-induced vascular smooth muscle
cells proliferation. Acta Biochim Biophys Sin (Shanghai).
45:875–881. 2013. View Article : Google Scholar
|
|
8
|
Masri B, Morin N, Cornu M, Knibiehler B
and Audigier Y: Apelin (65–77) activates p70 S6 kinase and is
mitogenic for umbilical endothelial cells. FASEB J. 18:1909–1911.
2004.PubMed/NCBI
|
|
9
|
Yang L, Su T, Lv D, Xie F, Liu W, Cao J,
Sheikh IA, Qin X, Li L and Chen L: ERK1/2 mediates lung
adenocarcinoma cell proliferation and autophagy induced by
apelin-13. Acta Biochim Biophys Sin (Shanghai). 46:100–111. 2014.
View Article : Google Scholar
|
|
10
|
Heo K, Kim YH, Sung HJ, et al:
Hypoxia-induced up-regulation of apelin is associated with a poor
prognosis in oral squamous cell carcinoma patients. Oral Oncol.
48:500–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Greeley GH Jr and Qiu S:
Immunohistochemical localization of apelin in human normal breast
and breast carcinoma. J Mol Histol. 39:121–124. 2008. View Article : Google Scholar
|
|
12
|
Poola I, DeWitty RL, Marshalleck JJ,
Bhatnagar R, Abraham J and Leffall LD: Identification of MMP-1 as a
putative breast cancer predictive marker by global gene expression
analysis. Nat Med. 11:481–483. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan XY, Xu J, Anzick SL, Zhang H, Trent
JM and Meltzer PS: Hybrid selection of transcribed sequences from
microdissected DNA: Isolation of genes within amplified region at
20q11-q13.2 in breast cancer. Cancer Res. 56:3446–3450.
1996.PubMed/NCBI
|
|
14
|
Anzick SL, Kononen J, Walker RL, Azorsa
DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and
Meltzer PS: AIB1, a steroid receptor coactivator amplified in
breast and ovarian cancer. Science. 277:965–968. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bautista S, Vallès H, Walker RL, Anzick S,
Zeillinger R, Meltzer P and Theillet C: In breast cancer,
amplification of the steroid receptor coactivator gene AIB1 is
correlated with estrogen and progesterone receptor positivity. Clin
Cancer Res. 4:2925–2929. 1998.PubMed/NCBI
|
|
16
|
Bouras T, Southey MC and Venter DJ:
Overexpression of the steroid receptor coactivator AIB1 in breast
cancer correlates with the absence of estrogen and progesterone
receptors and positivity for p53 and HER2/neu. Cancer Res.
61:903–907. 2001.PubMed/NCBI
|
|
17
|
List HJ, Reiter R, Singh B, Wellstein A
and Riegel AT: Expression of the nuclear coactivator AIB1 in normal
and malignant breast tissue. Breast Cancer Res Treat. 68:21–28.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou HJ, Yan J, Luo W, Ayala G, Lin SH,
Erdem H, Ittmann M, Tsai SY and Tsai MJ: SRC-3 is required for
prostate cancer cell proliferation and survival. Cancer Res.
65:7976–7983. 2005.PubMed/NCBI
|
|
19
|
Xu FP, Xie D, Wen JM, Wu HX, Liu YD, Bi J,
Lv ZL, Zeng YX and Guan XY: SRC-3/AIB1 protein and gene
amplification levels in human esophageal squamous cell carcinomas.
Cancer Lett. 245:69–74. 2007. View Article : Google Scholar
|
|
20
|
Luo JH, Xie D, Liu MZ, Chen W, Liu YD, Wu
GQ, Kung HF, Zeng YX and Guan XY: Protein expression and
amplification of AIB1 in human urothelial carcinoma of the bladder
and over-expression of AIB1 is a new independent prognostic marker
of patient survival. Int J Cancer. 122:2554–2561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Louie MC, Zou JX, Rabinovich A and Chen
HW: ACTR/AIB1 functions as an E2F1 coactivator to promote breast
cancer cell proliferation and antiestrogen resistance. Mol Cell
Biol. 24:5157–5171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torres-Arzayus MI, Font de Mora J, Yuan J,
Vazquez F, Bronson R, Rue M, Sellers WR and Brown M: High tumor
incidence and activation of the PI3K/AKT pathway in transgenic mice
define AIB1 as an oncogene. Cancer Cell. 6:263–274. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tilli MT, Reiter R, Oh AS, Henke RT,
McDonnell K, Gallicano GI, Furth PA and Riegel AT: Overexpression
of an N-terminally truncated isoform of the nuclear receptor
coactivator amplified in breast cancer 1 leads to altered
proliferation of mammary epithelial cells in transgenic mice. Mol
Endocrinol. 19:644–656. 2005. View Article : Google Scholar
|
|
24
|
O'Hara J, Vareslija D, McBryan J, et al:
AIB1:ERα transcriptional activity is selectively enhanced in
aromatase inhibitor-resistant breast cancer cells. Clin Cancer Res.
18:3305–3315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Font de Mora J and Brown M: AIB1 is a
conduit for kinase-mediated growth factor signaling to the estrogen
receptor. Mol Cell Biol. 20:5041–5047. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fereshteh MP, Tilli MT, Kim SE, Xu J,
O'Malley BW, Wellstein A, Furth PA and Riegel AT: The nuclear
receptor coactivator amplified in breast cancer-1 is required for
Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis
in mice. Cancer Res. 68:3697–3706. 2008. View Article : Google Scholar : PubMed/NCBI
|
